Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin

Analytical and Bioanalytical Chemistry

Volumn 391, Issue 2, 2008, Pages 577-585

  Brouwers, E E M ^a   Tibben, M M ^a   Pluim, D ^b   Rosing, H ^a   Boot, H ^b   Cats, A ^b   Schellens, J H M ^b,c   Beijnen, J H ^a,c  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

DNA adducts; ICP MS; Peripheral blood mononuclear cells; Platinum; Tissue

Indexed keywords

DNA; DRUG PRODUCTS; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; PATIENT TREATMENT; PLATINUM; TISSUE;

CISPLATIN; DNA ADDUCTS; PERIPHERAL BLOOD MONONUCLEAR CELLS;

TRACE ANALYSIS;

ANTINEOPLASTIC AGENT; CISPLATIN; ISOTOPE; PLATINUM;

ARTICLE; BLOOD; CHEMISTRY; DNA ADDUCT; HUMAN; MASS SPECTROMETRY; METHODOLOGY; MONONUCLEAR CELL; STOMACH TUMOR;

ANTINEOPLASTIC AGENTS; CISPLATIN; DNA ADDUCTS; HUMANS; ISOTOPES; LEUKOCYTES, MONONUCLEAR; MASS SPECTROMETRY; PLATINUM; STOMACH NEOPLASMS;

EID: 43049127160     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-008-2034-8     Document Type: Article

References (20)

1. 1. B Rosenberg L Vancamp T Krigas 1965 Nature 205 698 699 10.1038/205698a0 1:CAS:528:DyaF2MXns1aruw%3D%3D Rosenberg B, Vancamp L, Krigas T (1965) Nature 205:698–699
2. 2. JH Schellens J Ma AS Planting ME Burg van der E Meerten van M Boer-Dennert PI Schmitz G Stoter J Verweij 1996 Br J Cancer 73 1569 1575 1:STN:280:BymB283hsVc%3D Schellens JH, Ma J, Planting AS, van der Burg ME, van Meerten E, Boer-Dennert M, Schmitz PI, Stoter G, Verweij J (1996) Br J Cancer 73:1569–1575
3. 3. E Reed RJ Parker I Gill A Bicher M Dabholkar JA Vionnet F Bostick-Bruton R Tarone FM Muggia 1993 Cancer Res 53 3694 3699 1:STN:280:ByyA3sfmvFU%3D Reed E, Parker RJ, Gill I, Bicher A, Dabholkar M, Vionnet JA, Bostick-Bruton F, Tarone R, Muggia FM (1993) Cancer Res 53:3694–3699
4. 4. FJ Hoebers D Pluim M Verheij AJ Balm H Bartelink JH Schellens AC Begg 2006 Int J Cancer 119 750 756 10.1002/ijc.21919 Hoebers FJ, Pluim D, Verheij M, Balm AJ, Bartelink H, Schellens JH, Begg AC (2006) Int J Cancer 119:750–756
5. 5. AM Fichtinger-Schepman SD Velde-Visser van der HC Dijk-Knijnenburg AT Oosterom van RA Baan F Berends 1990 Cancer Res 50 7887 7894 1:CAS:528:DyaK3MXjsFGktg%3D%3D Fichtinger-Schepman AM, van der Velde-Visser SD, Dijk-Knijnenburg HC, van Oosterom AT, Baan RA, Berends F (1990) Cancer Res 50:7887–7894
6. 6. J Reedijk 1999 Chem Rev 99 2499 2510 10.1021/cr980422f 1:CAS:528:DyaK1MXlt12rsb8%3D Reedijk J (1999) Chem Rev 99:2499–2510
7. 7. CR Centerwall KA Tacka DJ Kerwood J Goodisman BB Toms RL Dubowy JC Dabrowiak 2006 Mol Pharmacol 70 348 355 Centerwall CR, Tacka KA, Kerwood DJ, Goodisman J, Toms BB, Dubowy RL, Dabrowiak JC (2006) Mol Pharmacol 70:348–355
8. 8. D Pluim M Maliepaard RC Waardenburg van JH Beijnen JHM Schellens 1999 Anal Biochem 275 30 38 10.1006/abio.1999.4302 1:CAS:528:DyaK1MXmvVyntbY%3D Pluim D, Maliepaard M, van Waardenburg RC, Beijnen JH, Schellens JHM (1999) Anal Biochem 275:30–38
9. 9. A Bonetti P Apostoli M Zaninelli F Pavanel M Colombatti GL Cetto T Franceschi L Sperotto R Leone 1996 Clin Cancer Res 2 1829 1835 1:STN:280:DyaK1M%2FjsFaitQ%3D%3D Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R (1996) Clin Cancer Res 2:1829–1835
10. 10. J Liu E Kraut J Bender R Brooks S Balcerzak M Grever H Stanley S D’Ambrosio R Gibson-D’Ambrosio KK Chan 2002 Cancer Chemother Pharmacol 49 367 374 10.1007/s00280-002-0426-6 1:CAS:528:DC%2BD38XjtFyls78%3D Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D’Ambrosio S, Gibson-D’Ambrosio R, Chan KK (2002) Cancer Chemother Pharmacol 49:367–374
11. 11. BW Cooper GJ Veal T Radivoyevitch MJ Tilby HJ Meyerson HM Lazarus ON Koc RJ Creger G Pearson GM Nowell D Gosky ST Ingalls CL Hoppel SL Gerson 2004 Clin Cancer Res 10 6830 6839 10.1158/1078-0432.CCR-04-0097 1:CAS:528:DC%2BD2cXpslGltLo%3D Cooper BW, Veal GJ, Radivoyevitch T, Tilby MJ, Meyerson HJ, Lazarus HM, Koc ON, Creger RJ, Pearson G, Nowell GM, Gosky D, Ingalls ST, Hoppel CL, Gerson SL (2004) Clin Cancer Res 10:6830–6839
12. 12. ES McDonald KR Randon A Knight AJ Windebank 2005 Neurobiol Dis 18 305 313 10.1016/j.nbd.2004.09.013 1:CAS:528:DC%2BD2MXos1yntQ%3D%3D McDonald ES, Randon KR, Knight A, Windebank AJ (2005) Neurobiol Dis 18:305–313
13. 13. JR Rice JL Gerberich DP Nowotnik SB Howell 2006 Clin Cancer Res 12 2248 2254 10.1158/1078-0432.CCR-05-2169 Rice JR, Gerberich JL, Nowotnik DP, Howell SB (2006) Clin Cancer Res 12:2248–2254
14. 14. K Yamada N Kato A Takagi M Koi H Hemmi 2005 Anal Bioanal Chem 382 1702 1707 10.1007/s00216-005-3339-5 Yamada K, Kato N, Takagi A, Koi M, Hemmi H (2005) Anal Bioanal Chem 382:1702–1707
15. 15. E Bjorn Y Nygren TT Nguyen C Ericson M Nojd P Naredi 2007 Anal Biochem 363 135 142 10.1016/j.ab.2007.01.006 Bjorn E, Nygren Y, Nguyen TT, Ericson C, Nojd M, Naredi P (2007) Anal Biochem 363:135–142
16. 16. D Garcia Sar M Montes-Bayon E Blanco Gonzalez A Sanz-Medel 2006 J Anal Atom Spectrom 21 861 868 10.1039/b603434a Garcia Sar D, Montes-Bayon M, Blanco Gonzalez E, Sanz-Medel A (2006) J Anal Atom Spectrom 21:861–868
17. 17. JG Morrison D Bissett IFD Stephens K McKay R Brown MA Graham AM Fichtinger-Schepman DJ Kerr 1993 Int J Oncol 2 33 37 1:CAS:528:DyaK3sXhtFKisrc%3D Morrison JG, Bissett D, Stephens IFD, McKay K, Brown R, Graham MA, Fichtinger-Schepman AM, Kerr DJ (1993) Int J Oncol 2:33–37
18. 18. Azim-Araghi A, Ottley CJ, Pearson DG, Tilby MJ (2003) Combination of ICP-MS and ion exchange chromatography permits analyses of specific cisplatin DNA modifications formed in cancer cells. In: Holland JG, Tanner SD (eds) Plasma source mass spectrometry. Royal Society of Chemistry, pp 66–73
19. 19. L Lustig S Zang B Michalke P Schramel W Beck 1997 Fresenius J Anal Chem 357 1157 1163 10.1007/s002160050323 Lustig L, Zang S, Michalke B, Schramel P, Beck W (1997) Fresenius J Anal Chem 357:1157–1163
20. 20. J Ma J Verweij AS Planting M Boer-Dennert HE Ingen van ME Burg van der G Stoter JH Schellens 1995 Br J Cancer 71 512 517 1:STN:280:ByqC1cnjslY%3D Ma J, Verweij J, Planting AS, Boer-Dennert M, van Ingen HE, van der Burg ME, Stoter G, Schellens JH (1995) Br J Cancer 71:512–517